Next 10 |
NRx Pharmaceuticals (NASDAQ: NRXP) , a clinical-stage biopharmaceutical company, has announced the pricing of its underwritten public offering. The offering is comprised of shares of NRXP common stock at $3.30 per share, resulting in gross proceeds of an estimated $2 million before stan...
2024-04-18 12:42:59 ET More on Mid-day movers & stocks. Canopy Growth Is Climbing, But It Won't Last Canopy Growth Corporation (CGC) Q3 2024 Earnings Call Transcript Canopy Growth: Reiterate Strong Sell, Dilutive Offering Likely First Of Many To Come Cano...
A look at the top 10 most actives in the United States SiNtx Technologies Inc. (SINT) rose 73.2% to $0.0646 on volume of 191,555,690 shares AGBA Group Holding Limited (AGBA) rose 245.0% to $1.38 on volume of 41,065,125 shares TIAN RUIXIANG Holdings Ltd (TIRX) rose 135.2% to $1.14 on volum...
2024-04-18 08:44:40 ET More on NRx Pharmaceuticals NRx Pharmaceuticals announces proposed underwritten public offering of common stock NRx Pharmaceuticals reports Q4 results Seeking Alpha’s Quant Rating on NRx Pharmaceuticals Historical earnings data f...
NRx Pharmaceuticals (NASDAQ:NRXP) Receives Notice from Nasdaq that the Company has Demonstrated Compliance with the Bid Price Requirement PR Newswire The Nasdaq Panel has determined to continue the listing of the Company's securities on The Nasdaq Stock Market and is closing t...
NRx Pharmaceuticals, Inc. Announces Pricing of $2.0 Million Underwritten Public Offering of Common Stock PR Newswire RADNOR, Pa. , April 18, 2024 /PRNewswire/ -- NRx Pharmaceuticals, Inc. (Nasdaq: NRXP), ("NRx Pharmaceuticals" or the "Company"), a clinical-stage ...
2024-04-17 16:51:07 ET More on NRx Pharmaceuticals NRX Pharmaceuticals, Inc. (NRXP) Q4 2023 Earnings Call Transcript NRx Pharmaceuticals reports Q4 results NRx Pharma to distribute HOPE Therapeutics stock, pay Ketamine royalty to holders Seeking Alpha’...
NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Announces New Data on NRX-101 Demonstrating No Damage to Intestinal and Vaginal Flora in Validated Rodent Models Compared to Standard Antibiotics: Potential Implications for Avoidance of C. Difficile infections PR Newswire New data demon...
NRx Pharmaceuticals (NASDAQ:NRXP) Announces Development of New, Proprietary Formulation of HTX-100 (IV Ketamine) PR Newswire Formulation based on prior patents by NRx founder Achieved pH neutral formulation of ketamine, potentially enabling both intravenous (IV) and subcut...
2024-04-12 09:01:35 ET More on premarket gainers & stock Cerus Corporation (CERS) Q4 2023 Earnings Call Transcript Globe Life Inc. (GL) Q4 2023 Earnings Call Transcript Alterity Therapeutics receives A$3.9M research & development tax incentive refund ...
News, Short Squeeze, Breakout and More Instantly...
NRX Pharmaceuticals Inc. Company Name:
NRXP Stock Symbol:
NASDAQ Market:
NRx Pharmaceuticals (NASDAQ: NRXP) , a clinical-stage biopharmaceutical company, has announced the pricing of its underwritten public offering. The offering is comprised of shares of NRXP common stock at $3.30 per share, resulting in gross proceeds of an estimated $2 million before stan...
U.S. stocks traded mostly lower toward the end of trading, with the NASDAQ Composite falling around 0.5% on Thursday. The Dow traded down 0.01% to ...
U.S. stocks traded higher midway through trading, with the S&P 500 gaining around 0.5% on Thursday. The Dow traded up 0.64% to 37,996.39 while ...